Futoshi Akiyama

8.8k total citations
251 papers, 6.1k citations indexed

About

Futoshi Akiyama is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Futoshi Akiyama has authored 251 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Cancer Research, 118 papers in Pathology and Forensic Medicine and 105 papers in Oncology. Recurrent topics in Futoshi Akiyama's work include Breast Cancer Treatment Studies (135 papers), Breast Lesions and Carcinomas (102 papers) and HER2/EGFR in Cancer Research (53 papers). Futoshi Akiyama is often cited by papers focused on Breast Cancer Treatment Studies (135 papers), Breast Lesions and Carcinomas (102 papers) and HER2/EGFR in Cancer Research (53 papers). Futoshi Akiyama collaborates with scholars based in Japan, United States and India. Futoshi Akiyama's co-authors include Goi Sakamoto, Takuji Iwase, Rie Horii, Fujio Kasumi, Takaaki Sato, Hitoshi Tsuda, Masafumi Kurosumi, Yoshinori Ito, F Kasumi and Naoko Honma and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Futoshi Akiyama

240 papers receiving 5.9k citations

Peers

Countries citing papers authored by Futoshi Akiyama

Since Specialization

Citations

This map shows the geographic impact of Futoshi Akiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Futoshi Akiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Futoshi Akiyama more than expected).

Fields of papers citing papers by Futoshi Akiyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Futoshi Akiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Futoshi Akiyama. The network helps show where Futoshi Akiyama may publish in the future.

Co-authorship network of co-authors of Futoshi Akiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Futoshi Akiyama. A scholar is included among the top collaborators of Futoshi Akiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Futoshi Akiyama. Futoshi Akiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intratumoral heterogeneity, treatment response, and survival outcome of ER‐positive HER2‐positive breast cancer 2023 ·Cancer Medicine ·(unknown), Hiroaki Inoue, Rie Horii, Futoshi Akiyama, Takayuki Ueno, Shinji Ohno, Shunji Takahashi	7
2	A Case of Breast Cancer with Hemosiderin Deposits Resembling Calcifications on Mammography 2017 ·(unknown), Yumi Miyagi, Takehiko Sakai, Naoya Gomi, Rie Horii, Futoshi Akiyama, Takuji Iwase, (unknown)	2
3	Eribulin mesylate may improve the sensitivity of endocrine therapy in metastatic breast cancer 2016 ·Annals of Oncology ·Kokoro Kobayashi, (unknown), (unknown), Ippei Fukada, Naoki Ishizuka, Rie Horii, Shunji Takahashi, Futoshi Akiyama, Takuji Iwase, Shinji Ohno	2
4	Impact of immunohistological subtypes on the long-term prognosis of patients with metastatic breast cancer 2015 ·Surgery Today ·Kokoro Kobayashi, Yoshinori Ito, Masaaki Matsuura, Ippei Fukada, Rie Horii, Shunji Takahashi, Futoshi Akiyama, Takuji Iwase, Yasuo Hozumi, Yoshikazu Yasuda, Kiyohiko Hatake	29
5	The cell cycle profiling-risk score based on CDK1 and 2 predicts early recurrence in node-negative, hormone receptor-positive breast cancer treated with endocrine therapy 2014 ·Cancer Letters ·Seung Jin Kim, Norikazu Masuda, Fumine Tsukamoto, Hideo Inaji, Futoshi Akiyama, Hiroshi Sonoo, Junichi Kurebayashi, Katsuhide Yoshidome, Masahiko Tsujimoto, Hiroyuki Takei, Shinobu Masuda, Seigo Nakamura, Shinzaburo Noguchi	12
6	Lapatinib-associated mucocutaneous toxicities are clinical predictors of improved progression-free survival in patients with human epidermal growth factor receptor (HER2)-positive advanced breast cancer 2014 ·Breast Cancer Research and Treatment ·Kazuhiro Araki, Ippei Fukada, Rie Horii, Shunji Takahashi, Futoshi Akiyama, Takuji Iwase, Yoshinori Ito	5
7	Prognostic significance of subtype and pathologic response in operable breast cancer; a pooled analysis of prospective neoadjuvant studies of JBCRG 2013 ·Breast Cancer ·Katsumasa Kuroi, Masakazu Toi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama	26
8	Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer 2010 ·Cancer Science ·Yoshinori Ito, Koichi Nagasaki, Yoshio Miki, Takuji Iwase, Futoshi Akiyama, Masaaki Matsuura, Rie Horii, Masujiro Makita, Nahomi Tokudome, Masaru Ushijima, Masataka Yoshimoto, Shunji Takahashi, Tetsuo Noda, Kiyohiko Hatake	2
9	Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years 2009 ·Breast Cancer Research ·Naoko Honma, Kaiyo Takubo, Motoji Sawabe, Tomio Arai, Futoshi Akiyama, Goi Sakamoto, Toshiaki Utsumi, Noriko Yoshimura, Nobuhiro Harada	4
10	What Causes Discrepancies in HER2 Testing for Breast Cancer? 2008 ·American Journal of Clinical Pathology ·Shinobu Umemura, R. Yoshiyuki Osamura, Futoshi Akiyama, Keiichi Honma, Masafumi Kurosumi, Hironobu Sasano, Satoshi Toyoshima, Hitoshi Tsuda, Josef Rüschoff, Goi Sakamoto	31
11	A CASE OF ADENOID CYSTIC CARCINOMA OF THE BREAST DIAGNOSED ITS HISTLOGIC TYPE BY ASPIRATION BIOPSY 2008 ·Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ·(unknown), (unknown), Futoshi Akiyama, Masujiro Makita, Rie Horii, Takuji Iwase	1
12	Endoscopic and Histologic Findings of Intraductal Lesions Presenting with Nipple Discharge 2006 ·The Breast Journal ·Masujiro Makita, Futoshi Akiyama, Naoya Gomi, Takuji Iwase, Fujio Kasumi, Goi Sakamoto	17
13	A case of carcinosarcoma of the breast 2005 ·Breast Cancer ·(unknown), (unknown), Takehiko Sakai, (unknown), (unknown), (unknown), Rie Horii, Futoshi Akiyama, Masahiko Tanabe, Keita Saito, (unknown), Fujio Kasumi	28
14	2003 ·Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening) ·Seiichiro Nishimura, (unknown), Masahiko Tanabe, Nahomi Tokudome, Keiichiro Tada, Masujiro Makita, Takashi Tada, Masataka Yoshimoto, Fujio Kasumi, Futoshi Akiyama, Goi Sakamoto	1
15	Evaluation of interobserver agreement in scoring immunohistochemical results of HER‐2/neu (c‐erbB‐2) expression detected by HercepTest, Nichirei polyclonal antibody, CB11 and TAB250 in breast carcinoma 2002 ·Pathology International ·Hitoshi Tsuda, Hironobu Sasano, Futoshi Akiyama, Masafumi Kurosumi, Tadashi Hasegawa, R. Yoshiyuki Osamura, Goi Sakamoto	32
16	2002 ·Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening) ·Kaoru Takahashi, Seiichiro Nishimura, Kumiko Tanaka, (unknown), Masujiro Makita, Masataka Yoshimoto, Fujio Kasumi, Hiroshi Sakuma, Futoshi Akiyama, Goi Sakamoto	2
17	Evaluation of HER2 status: For the treatment of metastatic breast cancers by humanized anti-HER2 monoclonal antibody (trastuzumab) (Pathological committee for optimal use of trastuzumab) 2001 ·Breast Cancer ·Shinobu Umemura, Goi Sakamoto, Hironobu Sasano, Hitoshi Tsuda, Futoshi Akiyama, Masafumi Kurosumi, Yutaka Tokuda, Toru Watanabe, Masakazu Toi, Tadashi Hasegawa, R. Yoshiyuki Osamura	11
18	Study in the Relationship between Risk Factors and Pattern of Recurrence after Complete Surgery for Adenocarcinoma of the Uterine Cervix 1997 ·Kuniko Utsugi, Yoshio Shimizu, (unknown), Futoshi Akiyama, Kazuhiro Yamauchi, Katsuhiko Hasumi	1
19	Cytological study of pure adenocarcinoma in situ and coexistence of adenocarcinoma in situ and squamous cell carcinoma of the uterine cervix. 1995 ·The Journal of the Japanese Society of Clinical Cytology ·Kuniko Utsugi, H Teshima, (unknown), Reiko Furuta, Futoshi Akiyama, (unknown), Kazuhiro Yamauchi, Katsuhiko Hasumi, (unknown)	0
20	Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. 1990 ·PubMed ·Takaaki Sato, Akira Tanigami, Kazuhiro Yamakawa, Futoshi Akiyama, Fujio Kasumi, Goi Sakamoto, Yusuke Nakamura	457

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact